Introduction
Hepatitis C virus (HCV) is a human pathogen causing chronic liver inflammatory disease. Most HCV infected patients (70%-80%) are chronically infected leading to liver fibrosis, cirrhosis and finally hepatocellular carcinoma [1] . It is estimated that approximately more than 170 million people or 2.5% of the world's population are chronically infected by HCV [2, 3] . Currently, HCV infected-liver diseases caused 500 000 people die annually [4] . Moreover, more
Objective: To evaluate the potential anti-hepatitis C virus (HCV) activities of Cladogynos orientalis Zipp. ex Span and to investigate the molecular mode of action. Methods: Ethanolic and water extracts from various parts of Cladogynos orientalis were examined for cytotoxicity by MTT assay. Sub-cytotoxic concentrations of the extracts were used for further determining anti-HCV activity using cell culture-derived HCV genotype 2a propagated in HepaRG cell line. Immunofluorescence assay was performed to observe the effect on viruses at the pre-entry step. Mode of action at the post-entry step was investigated for the viral RNA and protein expressions by real time RT-PCR and Western blotting assays, respectively.
Results: Although Cladogynos orientalis water extracts exhibited lower cytotoxicity than ethanolic extracts, all ethanolic extracts from roots, stems, and leaves of Cladogynos orientalis exhibited higher anti-HCV activities than water extracts. The highest anti-HCV activity was observed in infected cells treated with the extracts 5 h after absorption. No extracts showed pre-viral entry effect. At the post-viral entry step, only leaf ethanolic extracts inhibited NS5B expression, while all extracts did not inhibit HCV NS3 expression.
Conclusions: Cladogynos orientalis ethanolic extracts could be further studied and the major active compound needs to be identified as a promising source for anti-HCV agents. 
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HCV is an envelope, positive sense, single-stranded RNA virus belonging to genus Hepacivirus in Faviviridae family. The viral particle diameter is among 40-70 nm and classified into seven major genotypes (1-7) and several subtypes [7] . Each genotype has diversity level of nucleotides more than 30% while subtypes are only 15% [7] . The most prevalent HCV is genotype 1 (49.1%) and genotype 3 (17.9%) with about 137.7 million people infected, followed by genotype 4 and 2 [2, 8] . At present, there is no vaccine available for prevention of HCV infection [9] . Current therapy of HCV-infected patients is the combination of PEGylated interferon and ribavirin which can reach a sustained virologic response (SVR) only 50% for genotype 1 and 70%-80% for genotype 2 [10, 11] . In 2011, the United States Food and Drug Administration had approved 2 HCV NS3 protease inhibitor drugs, boceprevir and telaprevir, as direct-acting antiviral drugs (DAAs) for genotype 1. These drugs were used in triple combination with standard therapy and could increase SVR rates up to 70% in genotype 1 infected patient [12, 13] .
Shortly afterwards in 2013, simeprevir and sofosbuvir, new drugs with effective actions on protease and polymerase inhibitors were approved which showed outcomes of high SVR rates [14, 15] .
In October 2014, US-Food and Drug Administration approved combination of DAAs that was needless to use interferon or ribavirin to treat HCV infection. Combination of sofosbuvir and ledipasvir has shown 96%-99% SVR rates within 12-14 weeks [16, 17] . However, both of interferon and DAAs have many serious side effects and it may lead to HCV resistant problem [18] . In addition, DAAs are very expensive; therefore, some patients suffering from HCV infection could not receive the therapy. Hence, new therapeutic options with low cost and less adverse effect are still urgently required. [19] . Several parts of this plant possessed antioxidant and antibacterial activities against Streptococcus suis and Staphylococcus intermedius [20] . Klawikkan and colleagues reported anti-dengue viral activity of C. orientalis ethanolic extracts [21] . At present, there is still no report on anti-HCV activity of C. orientalis. Therefore, this study was aimed to investigate anti-HCV activity from water and ethanolic extracts of C. orientalis by using cell culture-derived-HCV (HCVcc).
All extracts were tested for their cytotoxicity by MTT assay and anti-HCV activity was evaluated by focus-formation inhibition test.
Moreover, the biologically active extracts were further examined for their mode of actions by real time RT-PCR and Western blotting.
Materials and methods

Cell culture and viruses
HepaRG and Huh-7 cell line were cultured in Dulbecco's Modified Eagle's Medium mixture nutrient F-12 (DMEM/F12) with 10% fetal bovine serum (FBS) containing 100 IU/mL penicillin and 100 µg/mL streptomycin (Invitrogen, USA). The cells were maintained at 37 曟 with 5% CO 2 . The plasmid pJFH-1 carrying the full-length cDNA of HCV genotype 2a was kindly provided by Prof. Takaji Wakita (National Institute of Infectious Diseases, Tokyo, Japan).
Production of HCV particle-derived cell culture from pJFH-1 (HCVcc)
HepaRG cell line was used to propagate HCVcc, as described previously [18] . Briefly, pJFH-1 was linearized by 
Determination of cell viability
Cytotoxicity assay was performed as previously described [21] .
Briefly, Huh-7 cells were seeded in 96-well plate at 1伊10 4 cells/well and incubated at 37 曟 with 5% CO 2 for 24 h. After incubation, the 
Determination of HCV protein expression levels
Huh-7 cell line was infected with HCVcc as described before. 
Statistical analyses
The results were represented by mean ± standard deviation (SD) of triplicate experiments. The data were analyzed by Prism statistical software (GraphPadInc.) and the differences between groups were tested using ANOVA followed by post-hoc tests (Tukey's HSD).
Results
Anti-HCV activity of C. orientalis extracts
The extracts of C. orientalis were determined for their cytotoxic effects on the human hepatocyte cell lines (Huh-7). The results indicated that C. orientalis water extracts exhibited lower cytotoxicity than ethanolic extracts. The 50% cytotoxicity concentrations (CC 50 ) of all water extracts were more than 1 000 µg/mL, while ethanolic extracts of roots, stems and leaves exhibited CC 50 at 371.69, 499.72 and 626.46 µg/mL, respectively ( Figure 1 ). Sub-cytotoxic concentrations of the extracts were further used to evaluate anti-HCV activity with HCVcc by MTT assay. Result showed that water extracts exhibited anti-HCV infection at less than 40% (Figure 2 ).
C. orientalis ethanolic extracts of roots, stems and leaves inhibited
HCVcc infection with 50% inhibitory concentrations (IC 50 ) at 2.38, 3.65, and 17.84 µg/mL, respectively. At 100 µg/mL, the root extract was too toxic and the inhibition percentage could not be calculated (Figure 2 ).
Effect of C. orientalis extracts on virus pre-entry step
From previous experiment, all ethanol extracts exhibited higher HCV inhibitory activity than water extracts. Therefore, the ethanolic extracts of C. orientalis were selected to investigate the effect on 
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Root extract Stem extract Leaf extract Figure 3 . Effect of Cladogynos orientalis ethanol extracts on HCV pre-entry. Data represent mean ± SD from triplicate experiment. Statistical analyses were performed using ANOVA followed by post-hoc tests ( * P < 0.05).
Effect of C. orientalis extracts on HCV protein expression levels
The effects of all extracts on HCV protein expressions were further investigated focusing on HCV NS3 and NS5B proteins, essential proteins for HCV RNA replication and also have been reported to be interesting targets for anti-HCV agents. According to the results, all extracts did not inhibit HCV NS3 expression, while only leaf ethanol extracts inhibited NS5B expression at the same level as IFN-毩 and ribavirin, used as positive controls ( Figure 5 ). In addition, C. orientalis stem and root extracts had no effect on NS3 and NS5B HCV protein expressions, similar to sofosbuvir.
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Discussion
To date, the development of effective, less toxic and cost-effective anti-HCV agents remains in high demand. Several plants have been extensively studied for their antiviral activity including Phyllanthus amarus, Nymphaea alba and Artocarpus heterophyllus [23] [24] [25] . Antidengue activity of ethanol extracts of C. orientalis Zipp. ex Span.
has also been reported [21, 26] . In this study, C. orientalis extracts were further investigated since dengue virus and HCV belonged to the same family. To study the potentiality of this plant on anti-HCV activity, ethanolic and water extracts of leaf, stem, and root were determined for their cytotoxic concentration. The results showed that all ethanol extracts had cytotoxicity in Huh-7 cell lines. Among three parts, root ethanol extract exhibited the highest cytotoxicity while water extracts had no toxic until the concentration up to 1 mg/mL. Therefore, subcytotoxic concentrations of the extracts were further used to evaluate anti HCV activity. Previous reports suggested that infected HCV could induce cytopathic effect in vitro which could be determined by MTT assay [27] . In this study, HepaRG HCVcc was used to examine dose-dependent anti-HCV activity of plant extracts.
The results indicated that all ethanolic extracts exhibited anti-HCV activity more potent than all water extracts. This could possibly be explained by active compounds of this plant which were more easily extracted from ethanol than water. Sithisarn et al. investigated the phytochemicals from water and ethanol extracts of C. orientalis and found that ethanol extracts contained higher numbers of compounds than water extracts [20] . In addition, previous studies suggested that HCV infection induced inflammatory cytokines and chemokines, or enzymes such as COX-2 in liver cells [28] . HCV-infected cells treated with high concentrations of compounds increased cell inflammation leading to cell death. Root ethanol extracts showed the highest cytotoxicity with more active compounds in the roots than in stems and leaves.
The effects of C. orientalis ethanolic extracts were further examined for both pre-entry and post-entry steps of HCV replication. It was clearly shown that all ethanolic extracts had no significant effect at the pre-entry step. When the post-entry step was examined, all ethanolic extracts could significantly inhibit HCV RNA synthesis.
This result suggested that C. orientalis ethanolic extract could enter the cell and act intracellularly to inhibit HCV RNA synthesis.
Moreover, leaf ethanol extracts could inhibit the expression of NS5B. Previous report has shown that C. orientalis leaves were rich in phenolics and flavonoids such as chlorogenic acid, catechin, epicatechin, caffeic acid, vanillic acid, coumaric acid, quercertin and rutin [19] . Among these, quercetin was the most abundant compound isolated. Recently, Bachmetov and colleagues reported that quercetin could suppress HCV NS3 protease activity [29] . In agreement with this finding, the results from this study suggested that infected cells treated with C. orientalis leaves ethanol extracts could inhibit NS3 protease activity affecting the downstream genome by which inhibiting the synthesis of mature viral proteins, NS5A and NS5B. It was noteworthy that quercetin was not presented in stems and roots of C. orientalis; therefore, no effect on HCV protein expression was observed from root and stem extracts [30, 31] . The results suggested that leaves extracts probably interfered the function of NS5B protein.
This phenomenon was frequently found when examined antiviral activity from plant extracts in concordance with previous reports [30] .
Infection with HCV is one of the major causes of liver inflammation worldwide. Hepatitis C is a slow acting virus causing a chronic illness that can be managed with a variety of approaches. Although 
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